BUZZ-Septerna rises after Wells Fargo upgrades to 'overweight'

Reuters11-14
BUZZ-Septerna rises after <a href="https://laohu8.com/S/EOD">Wells Fargo</a> upgrades to 'overweight'

** Shares of drug developer Septerna SEPN.O up ~2% at $19.55 premarket

** Wells Fargo upgrades stock to "overweight" from "equal weight," PT to $28 from $18

** Brokerage says it is confident on co's SEP-479's (oral PTH1R) safety profile, differentiation relative to co's prior program

** SEPN's study conducted on cynomolgus monkeys (cyno study) for compound called SEP-479 will prove it does not have bilirubin issues compared to previous drug SEP-786, which showed increase in bilirubin levels, brokerage says

** Wells Fargo says phase 1 results for co's SEP-631 compound will be important near-term catalyst, alongside SEP-479 compound coming out in late 2026

** As of last close, stock down ~16%, YTD

(Reporting by Koyena Das)

((koyena.das@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment